CURRENT APPROACHES AND NEW RESEARCH IN
MODERN SCIENCES
International scientific-online conference
100
GOUT AND ITS ASSOCIATION WITH GOUTY NEPHROPATHY:
AN ANALYSIS OF 46 PATIENTS
Rakhmatov A.M.
Zaripov S.I.
https://doi.org/10.5281/zenodo.14263759
Introduction
: Gout is a widespread metabolic disorder characterized by
chronic hyperuricemia, which leads to the deposition of monosodium urate
crystals in various tissues and joints. This accumulation results in acute
inflammatory arthritis and, over time, can lead to severe complications,
including gouty nephropathy. Gouty nephropathy is a pathological condition of
the kidneys caused by prolonged exposure to elevated uric acid levels, leading to
progressive renal-dysfunction.
This thesis examines the clinical and biochemical features of gout and its
renal complications, focusing specifically on the levels of creatinine and uric acid
in the serum of affected patients. By analyzing the data from 46 gout patients,
this study identifies critical trends and risk factors associated with the
progression of gout to nephropathy, especially among older individuals.
Materials and Methods
The study cohort consisted of 46 patients diagnosed with gout. Among
these, 43 were males, and 3 were females, reflecting the higher prevalence of the
disease in men. The age range of the participants was between 40 and 70 years,
ensuring a focus on adult and older populations who are more likely to develop
gout and its complications. Data collection included detailed demographic
information, clinical presentations, and biochemical markers such as serum
creatinine and uric acid levels. Patients were categorized into subgroups based
on age (younger than 50 years and older than 50 years) and the presence or
absence of gouty nephropathy.
Data:
1. Patients: 46 patients diagnosed with gout, including 3 females and 44
males.
2. Age Range: Patients are aged between 40 and 70 years.
3. Gouty Nephropathy: 20 male patients were diagnosed with gouty
nephropathy, with 15 of them being older than 50.
4. Biochemical Analysis Results: Creatinine Levels: 20 patients had creatinine
levels above 130 mmol/l (normal creatinine levels for men are 62-106 mmol/l,
and for women, 53-97 mmol/l).
Uric Acid Levels: All patients had elevated uric acid levels, confirming the
diagnosis of gout.
CURRENT APPROACHES AND NEW RESEARCH IN
MODERN SCIENCES
International scientific-online conference
101
Older Patients (Above 50 years): Among those over 50 years old, creatinine
levels were higher, exceeding 130 mmol/l, and uric acid levels were above 7
mg/dl (normal uric acid levels for men are 3.5-7.2 mg/dl, and for women, 2.6-6.0
mg/dl).
Analysis:
Creatinine Levels: Elevated creatinine levels indicate impaired
kidney function. The higher creatinine levels in patients over 50 suggest a
greater risk of developing gouty nephropathy. Monitoring creatinine is crucial in
assessing kidney damage in gout patients.
Uric Acid Levels: Elevated uric acid is characteristic of gout and is linked to the
formation of uric acid crystals in the kidneys and joints. The higher levels of uric
acid in patients over 50 indicate a more severe progression of gout and an
increased risk of nephropathy.
Clinical Implications
: The correlation between age and biochemical
markers shows that gout and its complications, such as gouty nephropathy, are
more prevalent in older individuals, and these patients require careful
monitoring and management.
Conclusion:
Elevated creatinine and uric acid levels are significant biochemical
markers in the diagnosis and progression of gout and gouty nephropathy.
Patients over the age of 50 are at higher risk of developing kidney complications,
making it essential to monitor these markers regularly and initiate early
treatment to prevent further damage.
References:
1.
Toto, R. L., & Johnson, R. J. (2017). Gout and hyperuricemia: An update on
pathophysiology,
diagnosis,
and
management.
Nephrology
Dialysis
Transplantation, 32(9), 1450-1460.
2.
Choi, H. K., & Curhan, G. (2007). Independent impact of gout on mortality
and risk for coronary heart disease. Circulation, 116(7), 894-900.
3.
Li, C., Hsieh, M. C., & Chang, S. J. (2015). Gout and kidney disease: Review
and update. Journal of Clinical Rheumatology, 21(6), 349-354.
4.
Abhishek, A., & Doherty, M. (2017). The epidemiology of gout: The UK
perspective. Rheumatology, 56(4), 476-484.
5.
Zhang, W., & Doherty, M. (2012). Gout management and its impact on the
burden of disease in developed countries. Arthritis & Rheumatism, 64(4), 1101-
1111.
6.
Jabbarov, O. O., Maksudova, M. H., Mirzayeva, G. P., & Rakhmatov, A. M.
(2023). The Relationship of Blood Group with Human Diseases. Web of
Semantic: Universal Journal on Innovative Education, 2(3), 331-334.
CURRENT APPROACHES AND NEW RESEARCH IN
MODERN SCIENCES
International scientific-online conference
102
7.
Rakhmatov, A. M., & Jabbarov, A. A. KodirovaSh. A., Jumanazarov SB
(2022).
CLINICAL
MANIFESTATIONS
OF
GOUTHY
NEPHROPATHY.
THEORETICAL ASPECTS IN THE FORMATION OF PEDAGOGICAL SCIENCES, 1
(6), 140–141.
8.
Fayzullaevna, M. G., Otakhanovich, J. O., Tokhirovna, B. N., Mamatovich, R.
A., & Bakhadirovich, J. S. (2022). Gout Therapy With Reduced Kidney Function.
Central Asian Journal of Medical and Natural Science, 3(6), 198-203.
